Literature DB >> 26768613

MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression.

Bairong Xia1, Huiyan Li2, Shanshan Yang1, Tianbo Liu1, Ge Lou3.   

Abstract

Epithelial ovarian cancer (EOC) is a common type of gynecologic cancer, which accounts for the majority of deaths among all gynecologic malignant tumors in developed countries. A series of recent studies suggested that miR-381 might play important roles in the development of various cancer types. However, the biological function of miR-381 in EOC remains to be investigated. We examined the levels of miR-381 expression in EOC tissues and cell lines. We identified miR-381 target genes by bioinformatic prediction. We also characterized the phenotype regarding cell proliferation, cell migration, and cell invasion in EOC cells lines with altered expression levels of both miR-381 and its target gene, YY1. The expression levels of miR-381 were downregulated in EOC tissues and cell lines. Overexpression of miR-381 significantly inhibited EOC cell proliferation, migration, and invasion. Restoration of YY1 expression partially reversed the phenotype induced by miR-381 overexpression. Knockdown of miR-381 target gene, YY1, mimicked the phenotype induced by miR-381 overexpression. MiR-381 regulated EOC cell through miR-381/YY1/p53 and miR-381/YY1/Wnt signaling axis. We concluded that miR-381 inhibited EOC cell proliferation, migration, and invasion, at least in part, via suppressing YY1 expression.

Entities:  

Keywords:  Cell invasion; Cell migration; Cell proliferation; Epithelial ovarian cancer; YY1; miR-381

Mesh:

Substances:

Year:  2016        PMID: 26768613     DOI: 10.1007/s13277-016-4805-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  45 in total

1.  Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein.

Authors:  Y Shi; E Seto; L S Chang; T Shenk
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

2.  Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis.

Authors:  Qian Zhang; Qingchao Tang; Dandan Qin; Lei Yu; Rui Huang; Guixiang Lv; Zhaoxia Zou; Xiao-chen Jiang; Chendan Zou; Wei Liu; Jing Luo; Zhixun Zhao; Shan Muhammad; Guiyu Wang; Ying-gang Chen; Xishan Wang
Journal:  Mol Cell Biol       Date:  2015-01-12       Impact factor: 4.272

Review 3.  MicroRNAs-mediated cell fate in triple negative breast cancers.

Authors:  Xinbing Sui; Xian Wang; Weidong Han; Da Li; Yinghua Xu; Fang Lou; Jichun Zhou; Xidong Gu; Jing Zhu; Cheng Zhang; Hongming Pan
Journal:  Cancer Lett       Date:  2015-03-03       Impact factor: 8.679

Review 4.  MicroRNAs in biological processes and carcinogenesis.

Authors:  Hirotaka Osada; Takashi Takahashi
Journal:  Carcinogenesis       Date:  2006-10-06       Impact factor: 4.944

5.  Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer.

Authors:  Philipp Harter; Zelal M Muallem; Christine Buhrmann; Dietmar Lorenz; Christine Kaub; Rita Hils; Stefan Kommoss; Florian Heitz; Alexander Traut; Andreas du Bois
Journal:  Gynecol Oncol       Date:  2011-03-17       Impact factor: 5.482

6.  Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer.

Authors:  T Oishi; J Kigawa; Y Minagawa; M Shimada; M Takahashi; N Terakawa
Journal:  Obstet Gynecol       Date:  1998-04       Impact factor: 7.661

7.  Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis.

Authors:  Yen-Nien Liu; JuanJuan Yin; Ben Barrett; Heather Sheppard-Tillman; Dongmei Li; Orla M Casey; Lei Fang; Paul G Hynes; Amir H Ameri; Kathleen Kelly
Journal:  Mol Cell Biol       Date:  2015-03-23       Impact factor: 4.272

Review 8.  Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis.

Authors:  Mark Harries; Martin Gore
Journal:  Lancet Oncol       Date:  2002-09       Impact factor: 41.316

9.  Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma.

Authors:  Wei Kang; Joanna H M Tong; Anthony W H Chan; Junhong Zhao; Yujuan Dong; Shiyan Wang; Weiqin Yang; Frankie M C Sin; Simon S M Ng; Jun Yu; Alfred S L Cheng; Ka Fai To
Journal:  J Transl Med       Date:  2014-03-28       Impact factor: 5.531

10.  miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.

Authors:  Bairong Xia; Shanshan Yang; Tianbo Liu; Ge Lou
Journal:  Mol Cancer       Date:  2015-03-11       Impact factor: 27.401

View more
  31 in total

1.  MicroRNA-381 suppresses proliferation and invasion of prostate cancer cells through downregulation of the androgen receptor.

Authors:  Xin Rui; Ting-Ting Gu; Hua-Feng Pan; Si-Liang Shao; Hong-Xiang Shao
Journal:  Oncol Lett       Date:  2019-06-12       Impact factor: 2.967

2.  UBE2C promotes rectal carcinoma via miR-381.

Authors:  Yan Zhang; Suli Tian; Xiaodong Li; Yanchao Ji; Zhongcheng Wang; Chang Liu
Journal:  Cancer Biol Ther       Date:  2018-01-19       Impact factor: 4.742

Review 3.  Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta-analysis.

Authors:  Padacherri Vethil Jishnu; Pradyumna Jayaram; Vaibhav Shukla; Vinay Koshy Varghese; Deeksha Pandey; Krishna Sharan; Sanjiban Chakrabarty; Kapaettu Satyamoorthy; Shama Prasada Kabekkodu
Journal:  Clin Exp Metastasis       Date:  2019-12-07       Impact factor: 5.150

4.  MiR-381 inhibits migration and invasion in human gastric carcinoma through downregulatedting SOX4.

Authors:  Mingming Zhang; Shishu Huang; Dan Long
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

5.  miR-381-3p suppresses the proliferation of oral squamous cell carcinoma cells by directly targeting FGFR2.

Authors:  Xiao Yang; Huibing Ruan; Xi Hu; Anyi Cao; Li Song
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

6.  Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.

Authors:  Zhanzhan Xu; Yu Zhou; Yexuan Cao; Thi Lan Anh Dinh; Jing Wan; Min Zhao
Journal:  Med Oncol       Date:  2016-10-18       Impact factor: 3.064

Review 7.  Molecular mechanisms underlining the role of metformin as a therapeutic agent in lung cancer.

Authors:  Ali Fatehi Hassanabad; Kelsey T MacQueen
Journal:  Cell Oncol (Dordr)       Date:  2020-10-30       Impact factor: 6.730

8.  KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells.

Authors:  Hong Chen; Bairong Xia; Tianbo Liu; Mei Lin; Ge Lou
Journal:  Cancer Cell Int       Date:  2016-09-26       Impact factor: 5.722

9.  WISP-1 positively regulates angiogenesis by controlling VEGF-A expression in human osteosarcoma.

Authors:  Hsiao-Chi Tsai; Huey-En Tzeng; Chun-Yin Huang; Yuan-Li Huang; Chun-Hao Tsai; Shih-Wei Wang; Po-Chuan Wang; An-Chen Chang; Yi-Chin Fong; Chih-Hsin Tang
Journal:  Cell Death Dis       Date:  2017-04-13       Impact factor: 8.469

10.  Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma.

Authors:  Yunchao Li; Chunhua Zhao; Zhibin Yu; Jiarui Chen; Xiaoling She; Peiyao Li; Changhong Liu; Yan Zhang; Jianbo Feng; Haijuan Fu; Bing Wang; Lei Kuang; Lei Li; Guohua Lv; Minghua Wu
Journal:  Oncotarget       Date:  2016-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.